Skip to main content
. 2021 Feb 4;35(5):1405–1417. doi: 10.1038/s41375-021-01146-z

Fig. 1. MN1-driven leukemia can be established in the absence of Kmt2a SET domain.

Fig. 1

A Serial replating of in vitro MN1-transformed Kmt2a SET−/− and Kmt2a SETwt CMP. Colony numbers (left) and cell numbers (right) per 500 cells plated in duplicate. Error bars represent mean ± SEM of three biological replicates over two independent experiments. ns = non-significant, unpaired double-sided t-test. B Survival of in vitro MN1-transformed Kmt2a SET−/− (n = 13) and Kmt2a SETwt (n = 7) CMP recipients. Two independent experiments. p = ns, Log rank (Mantel–Cox) test. C Leukemia burden at the time of sacrifice as measured by percentage of GFP+ cells in the bone marrow (left), spleen weights (middle) and total white blood cell count (WBC, right). Error bars represent mean ± SEM for n = 7 Kmt2a SETwt, n = 11 Kmt2a SET−/−. p = ns, unpaired double-sided t-test.